<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="research-article" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0150335</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-46600</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer risk factors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Carcinogenesis</subject><subj-group><subject>Cancer stem cells</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Stem cells</subject><subj-group><subject>Cancer stem cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell processes</subject><subj-group><subject>Cell cycle and cell division</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Hematologic cancers and related disorders</subject><subj-group><subject>Leukemias</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Hematology</subject><subj-group><subject>Hematologic cancers and related disorders</subject><subj-group><subject>Leukemias</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Bioassays and physiological analysis</subject><subj-group><subject>Cell analysis</subject><subj-group><subject>Cell division analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Endocrine system</subject><subj-group><subject>Thyroid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Endocrine system</subject><subj-group><subject>Thyroid</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Carcinogenesis</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Lack of Correlation between Stem-Cell Proliferation and Radiation- or Smoking-Associated Cancer Risk</article-title>
<alt-title alt-title-type="running-head">Stem-Cell Division and Environmental Cancer Risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Little</surname>
<given-names>Mark P.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hendry</surname>
<given-names>Jolyon H.</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Puskin</surname>
<given-names>Jerome S.</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Rockville, Maryland, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Christie Medical Physics and Engineering, Christie Hospital and University of Manchester, Manchester, United Kingdom</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Radiation Protection Division, United States Environmental Protection Agency, Washington, DC, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Matsuo</surname>
<given-names>Keitaro</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Aichi Cancer Center Research Institute, JAPAN</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing risks exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: MPL JHH JSP. Performed the experiments: MPL. Analyzed the data: MPL. Contributed reagents/materials/analysis tools: MPL. Wrote the paper: MPL JHH JSP.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">mark.little@nih.gov</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>3</issue>
<elocation-id>e0150335</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>2</month>
<year>2016</year>
</date>
</history>
<permissions>
<license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">
<license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">Creative Commons CC0</ext-link> public domain dedication.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0150335"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>A recent paper by Tomasetti and Vogelstein (<italic>Science</italic> 2015 <bold>347</bold> 78–81) suggested that the variation in natural cancer risk was largely explained by the total number of stem-cell divisions, and that most cancers arose by chance. They proposed an extra-risk score as way of distinguishing the effects of the stochastic, replicative component of cancer risk from other causative factors, specifically those due to the external environment and inherited mutations.</p>
</sec>
<sec id="sec002">
<title>Objectives</title>
<p>We tested the hypothesis raised by Tomasetti and Vogelstein by assessing the degree of correlation of stem cell divisions and their extra-risk score with radiation- and tobacco-associated cancer risk.</p>
</sec>
<sec id="sec003">
<title>Methods</title>
<p>We fitted a variety of linear and log-linear models to data on stem cell divisions per year and cumulative stem cell divisions over lifetime and natural cancer risk, some taken from the paper of Tomasetti and Vogelstein, augmented using current US lifetime cancer risk data, and also radiation- and tobacco-associated cancer risk.</p>
</sec>
<sec id="sec004">
<title>Results</title>
<p>The data assembled by Tomasetti and Vogelstein, as augmented here, are inconsistent with the power-of-age relationship commonly observed for cancer incidence and the predictions of a multistage carcinogenesis model, if one makes the strong assumption of homogeneity of numbers of driver mutations across cancer sites. Analysis of the extra-risk score and various other measures (number of stem cell divisions per year, cumulative number of stem cell divisions over life) considered by Tomasetti and Vogelstein suggests that these are poorly predictive of currently available estimates of radiation- or smoking-associated cancer risk–for only one out of 37 measures or logarithmic transformations thereof is there a statistically significant correlation (<italic>p</italic>&lt;0.05) with radiation- or smoking-associated risk.</p>
</sec>
<sec id="sec005">
<title>Conclusions</title>
<p>The data used by Tomasetti and Vogelstein are in conflict with predictions of a multistage model of carcinogenesis, under the assumption of homogeneity of numbers of driver mutations across most cancer sites. Their hypothesis that if the extra-risk score for a tissue type is high then one would expect that environmental factors would play a relatively more important role in that cancer’s risk is in conflict with the lack of correlation between the extra-risk score and other stem-cell proliferation indices and radiation- or smoking-related cancer risk.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The work of MPL was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="6"/>
<page-count count="16"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All the data used for our analysis are given in the main part of the present paper, in Tables <xref ref-type="table" rid="pone.0150335.t001">1</xref> and <xref ref-type="table" rid="pone.0150335.t002">2</xref>, and are all derived from information that is already published, and therefore publicly available. We have also uploaded all datasets used as well as all relevant R code as <xref ref-type="supplementary-material" rid="pone.0150335.s002">S2 Text</xref> and <xref ref-type="supplementary-material" rid="pone.0150335.s003">S3 Text</xref>, respectively.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec006" sec-type="intro">
<title>Introduction</title>
<p>Stem cells are a type of cell in each tissue that are responsible for maintaining tissue homeostasis. There is increasing attention devoted to stem cells and their role in the carcinogenic process [<xref ref-type="bibr" rid="pone.0150335.ref001">1</xref>]. A recent paper of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] aroused considerable interest, and suggested that “the lifetime risk of cancers of many different types [was] strongly correlated … with the total number of divisions of the normal self-renewing [stem] cells”. Tomasetti and Vogelstein suggested a causal interpretation of their findings, stating that “the incorporation of a replicative component as a … quantitative determinant of cancer risk forces rethinking of our notions of cancer causation. The contribution of the classic determinants (external environment and heredity) to [replicative, cell-division associated] tumors is minimal. Even for [deterministic, non-replicative] tumors, however, replicative [cell-division associated] effects are essential” and that “our analysis shows that stochastic effects associated with DNA replication contribute in a substantial way to human cancer incidence in the United States” [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>].</p>
<p>Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] analyzed data on 31 cancer types, correlating natural cancer risk for the particular tissue with its total number of stem-cell divisions. They suggested that the high degree of correlation (<italic>ρ</italic> = 0.804, 95% CI 0.63, 0.90), and the relatively high R<sup>2</sup> (0.646, 95% CI 0.395, 0.813) implied that a high proportion, “65% … of the differences in cancer risk among various tissues can be explained by the total number of stem cell divisions in those tissues”. Therefore they attributed a large part of the variation in cancer risk to chance or “bad luck”, specifically the stochastic effects of DNA replication-induced mutations. Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] defined an extra-risk score (ERS) for the purpose of distinguishing “the effects of this stochastic, replicative component from other causative factors—that is, those due to the external environment and inherited mutations”.</p>
<p>One of the more common patterns in the age-incidence curves for epithelial cancers is that the incidence rate varies approximately as <italic>C</italic>[age]<sup><italic>β</italic></sup> for some constants <italic>C</italic> and <italic>β</italic>. For most epithelial cancers in adulthood, the exponent <italic>β</italic> of age seems to lie between 4 and 6 [<xref ref-type="bibr" rid="pone.0150335.ref003">3</xref>]. The so-called multistage model of carcinogenesis of Armitage and Doll [<xref ref-type="bibr" rid="pone.0150335.ref004">4</xref>] was developed as a way of accounting for this approximately log-log variation of cancer incidence with age. Much use has been made of the Armitage-Doll multistage model as a framework for understanding the time course of carcinogenesis, particularly for modeling effects of various types of occupational and environmental exposures, and the interaction of different carcinogens [<xref ref-type="bibr" rid="pone.0150335.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0150335.ref009">9</xref>]. The Armitage-Doll model has also been used to determine the number of driver-gene mutations associated with two types of cancer [<xref ref-type="bibr" rid="pone.0150335.ref010">10</xref>]. The Armitage-Doll model [<xref ref-type="bibr" rid="pone.0150335.ref004">4</xref>] supposes that a malignant neoplasm arises from a normal cell as a result of <italic>k</italic> irreversible heritable changes (so called “driver mutations”). At a rate of <italic>λ</italic><sub><italic>i</italic></sub>(<italic>t</italic>) per cell per unit time, at age <italic>t</italic> the cells in the compartment which have accumulated <italic>i</italic>−1 heritable driver mutations acquire one more. If the expected number of cells in the compartment which have accumulated <italic>i</italic> heritable driver mutational changes is given by <italic>N</italic><sub><italic>i</italic></sub>(<italic>t</italic>) (with <italic>N</italic><sub>0</sub> stem cells per tissue), then if the driver mutation rates are assumed constant (<italic>λ</italic><sub><italic>m</italic></sub>(<italic>t</italic>) ≡ <italic>λ</italic><sub><italic>m</italic></sub>) the cancer incidence rate at age <italic>t</italic> is approximately given [<xref ref-type="bibr" rid="pone.0150335.ref011">11</xref>] by:
<disp-formula id="pone.0150335.e001">
<alternatives>
<graphic id="pone.0150335.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mi> </mml:mi><mml:mo>≈</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>…</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>/</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>!</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(1)</label>
</disp-formula></p>
<p>This suggests that to account for the observed variation in cancer incidence and mortality rates of <italic>C</italic>[age]<sup><italic>β</italic></sup> with <italic>β</italic> between 4 and 6 [<xref ref-type="bibr" rid="pone.0150335.ref003">3</xref>], the number of driver mutation stages <italic>k</italic> should lie between 5 and 7.</p>
<p>This model can be easily generalized to take account of intermediate compartment growth rates in the <italic>k</italic> compartments, as has been done by Tomasetti <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref010">10</xref>], based on approximations of Durrett and Moseley [<xref ref-type="bibr" rid="pone.0150335.ref012">12</xref>]. Assuming that the growth rate induced by the <italic>i</italic>th driver mutation is <italic>g</italic><sub><italic>i</italic></sub> then the cancer risk becomes:
<disp-formula id="pone.0150335.e002">
<alternatives>
<graphic id="pone.0150335.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e002" xlink:type="simple"/>
<mml:math display="block" id="M2">
<mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>≈</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mrow/><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:msup><mml:msub><mml:mi>λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msup><mml:mrow/><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msup><mml:mo>…</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msup><mml:mrow/><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>/</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>!</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(2)</label>
</disp-formula></p>
<p>Expression (2) implies that the lifetime cancer risk (corrected for mortality from other causes), <italic>CR</italic>, is approximately:
<disp-formula id="pone.0150335.e003">
<alternatives>
<graphic id="pone.0150335.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e003" xlink:type="simple"/>
<mml:math display="block" id="M3">
<mml:mrow><mml:mi>C</mml:mi><mml:mi>R</mml:mi><mml:mo>≈</mml:mo><mml:munderover><mml:mo>∫</mml:mo><mml:mn>0</mml:mn><mml:mi>L</mml:mi></mml:munderover><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mrow/><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:msup><mml:msub><mml:mi>λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msup><mml:mrow/><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msup><mml:mo>…</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msup><mml:mrow/><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msup><mml:mi>L</mml:mi><mml:mi>k</mml:mi></mml:msup><mml:mo>/</mml:mo><mml:mi>k</mml:mi><mml:mo>!</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(3)</label>
</disp-formula>
where <italic>L</italic> is the expected lifetime. If all mutation rates are equal (<italic>λ</italic><sub><italic>m</italic></sub> ≡ <italic>λ</italic>) this (approximately) reduces to:
<disp-formula id="pone.0150335.e004">
<alternatives>
<graphic id="pone.0150335.e004g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e004" xlink:type="simple"/>
<mml:math display="block" id="M4">
<mml:mrow><mml:mi>C</mml:mi><mml:mi>R</mml:mi><mml:mo>≈</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>L</mml:mi><mml:mi>k</mml:mi></mml:msup><mml:msup><mml:mi>λ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:msup><mml:mo>/</mml:mo><mml:mi>k</mml:mi><mml:mo>!</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(4)</label>
</disp-formula></p>
<p>Since the expected number of stem-cell divisions over life, <italic>D</italic>, is given by:
<disp-formula id="pone.0150335.e005">
<alternatives>
<graphic id="pone.0150335.e005g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e005" xlink:type="simple"/>
<mml:math display="block" id="M5">
<mml:mrow><mml:mi>D</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mi>L</mml:mi><mml:mi>λ</mml:mi></mml:mrow>
</mml:math>
</alternatives>
<label>(5)</label>
</disp-formula>
this implies that:
<disp-formula id="pone.0150335.e006">
<alternatives>
<graphic id="pone.0150335.e006g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e006" xlink:type="simple"/>
<mml:math display="block" id="M6">
<mml:mrow><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>C</mml:mi><mml:mi>R</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>≈</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>D</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo><mml:mo>+</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>+</mml:mo><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo><mml:mo>−</mml:mo><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>k</mml:mi><mml:mo>!</mml:mo><mml:mo stretchy="false">]</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(6)</label>
</disp-formula>
where:
<disp-formula id="pone.0150335.e007">
<alternatives>
<graphic id="pone.0150335.e007g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e007" xlink:type="simple"/>
<mml:math display="block" id="M7">
<mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
<label>(7)</label>
</disp-formula>
i.e. cancer rate should be proportional to the <italic>F</italic>((<italic>g</italic><sub><italic>i</italic></sub>),<italic>k</italic>)th power of the expected number of cell divisions per stem cell, <italic>D</italic> / <italic>N</italic><sub>0</sub>, and a linear function of the number of stem cells, <italic>N</italic><sub>0</sub>. It is also proportional to the [<italic>k</italic>−<italic>F</italic>((<italic>g</italic><sub><italic>i</italic></sub>),<italic>k</italic>)]th power of the expected lifetime, <italic>L</italic>, but as [<italic>k</italic>−<italic>F</italic>((<italic>g</italic><sub><italic>i</italic></sub>),<italic>k</italic>)] is assumed to be constant across tissues (an assumption discussed and analyzed below), as is <italic>L</italic>, this term together with the final −ln[<italic>k</italic>!] term are constant. As pointed out by Tomasetti <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref010">10</xref>], there is little information on the growth rates <italic>g</italic><sub><italic>i</italic></sub>. Following Tomasetti <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref010">10</xref>] we shall therefore assume that the fitness advantage added by each successive driver mutation is constant, resulting in <italic>g</italic><sub>1</sub> / <italic>g</italic><sub><italic>k</italic></sub> = 1 / <italic>k</italic>, so that:
<disp-formula id="pone.0150335.e008">
<alternatives>
<graphic id="pone.0150335.e008g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e008" xlink:type="simple"/>
<mml:math display="block" id="M8">
<mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:mstyle></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(8)</label>
</disp-formula></p>
<p>The adequacy of approximation (8) can be gauged by the fact that with <italic>k</italic> = 5 the left hand side of the expression can be computed to be 3.08, compared with the right hand side of 1 + ln[5] = 2.61, and with <italic>k</italic> = 7 the left hand side of expression (8) can be computed to be 3.45, compared with the right hand side 1 + ln[7] = 2.95. However, we do not use approximation (8) further here. The only property we shall need of <italic>F</italic>((<italic>g</italic><sub><italic>i</italic></sub>),<italic>k</italic>), which follows immediately from inspection of expressions (7) and (8), is that it be a monotonic increasing function of <italic>k</italic>.</p>
<p>We suggest a number of problems with the interpretation that Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] provide. These comprise:</p>
<list list-type="order">
<list-item><p>considerations arising from the standard multistage carcinogenesis model of Armitage and Doll [<xref ref-type="bibr" rid="pone.0150335.ref004">4</xref>] discussed above; and</p></list-item>
<list-item><p>analysis of radiation- or smoking-associated cancer risk in relation to the ERS and various other measures considered by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>].</p></list-item>
</list>
<p>All analysis is based on the data presented by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>], and is given in Tables <xref ref-type="table" rid="pone.0150335.t001">1</xref> and <xref ref-type="table" rid="pone.0150335.t002">2</xref> and <xref ref-type="supplementary-material" rid="pone.0150335.s002">S2 Text</xref>. Analysis of this data in the light of consideration (a) is given in <xref ref-type="table" rid="pone.0150335.t003">Table 3</xref>, and analysis in the light of consideration (b) in Tables <xref ref-type="table" rid="pone.0150335.t004">4</xref>–<xref ref-type="table" rid="pone.0150335.t006">6</xref>.</p>
<table-wrap id="pone.0150335.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150335.t001</object-id>
<label>Table 1</label> <caption><title>Summary data on radiation-associated cancer risk and various tissue parameters, reproduced in part from Tomasetti &amp; Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] and UNSCEAR [unless otherwise indicated taken from Table 70 in Annex A of [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>]]</title></caption>
<alternatives>
<graphic id="pone.0150335.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">Cancer type</th>
<th align="center" rowspan="2">US lifetime natural cancer incidence [<xref ref-type="bibr" rid="pone.0150335.ref013">13</xref>]</th>
<th align="center" rowspan="2">Number of stem cells in tissue of origin</th>
<th align="center" rowspan="2">Numbers of divisions of each stem cell per year</th>
<th align="center" rowspan="2">Numbers of divisions of each stem cell over life</th>
<th align="center" rowspan="2">Number of divisions of all stem cell over lifetime</th>
<th align="center" rowspan="2">Extra Risk Score (ERS)</th>
<th align="center" colspan="4">Radiation exposure-induced cancer incidence risk (percent per Sv<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref> incidence risk (evaluated at 1 Sv<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref> for current Japanese population [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>])</th>
</tr>
<tr>
<th align="center">Excess relative risk (ERR) model</th>
<th align="center">Excess absolute risk (EAR) model</th>
<th align="center">BEIR VII [<xref ref-type="bibr" rid="pone.0150335.ref019">19</xref>] weighted ERR/EAR model</th>
<th align="center">ICRP [<xref ref-type="bibr" rid="pone.0150335.ref018">18</xref>] weighted ERR/EAR model</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Chronic lymphocytic leukemia</td>
<td align="center">0.006</td>
<td align="center">1.35 x 10<sup>8</sup></td>
<td align="center">12</td>
<td align="center">960</td>
<td align="center">1.30 x 10<sup>11</sup></td>
<td align="center">-24.69</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">All leukemia</td>
<td align="center">0.014</td>
<td align="center">1.35 x 10<sup>8</sup></td>
<td align="center">12</td>
<td align="center">960</td>
<td align="center">1.30 x 10<sup>11</sup></td>
<td align="center">-20.60</td>
<td align="center">0.69<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td>
<td align="center">0.86<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td>
<td align="center">0.74<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td>
<td align="center">0.86<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left">Basal cell carcinoma</td>
<td align="center">0.3<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td>
<td align="center">5.82 x 10<sup>9</sup></td>
<td align="center">7.6</td>
<td align="center">608</td>
<td align="center">3.55 x 10<sup>12</sup></td>
<td align="center">-6.56</td>
<td align="center">0.23<xref ref-type="table-fn" rid="t001fn004"><sup>d</sup></xref></td>
<td align="center">0.55<xref ref-type="table-fn" rid="t001fn004"><sup>d</sup></xref></td>
<td align="center">0.33<xref ref-type="table-fn" rid="t001fn004"><sup>d</sup></xref></td>
<td align="center">0.39<xref ref-type="table-fn" rid="t001fn004"><sup>d</sup></xref></td>
</tr>
<tr>
<td align="left">Colon cancer</td>
<td align="center">0.045</td>
<td align="center">2.00 x 10<sup>8</sup></td>
<td align="center">73</td>
<td align="center">5840</td>
<td align="center">1.17 x 10<sup>12</sup></td>
<td align="center">-16.25</td>
<td align="center">1.3</td>
<td align="center">1.36</td>
<td align="center">1.32</td>
<td align="center">1.33</td>
</tr>
<tr>
<td align="left">Esophageal cancer</td>
<td align="center">0.005</td>
<td align="center">8.64 x 10<sup>5</sup></td>
<td align="center">17.4</td>
<td align="center">1390</td>
<td align="center">1.20 x 10<sup>9</sup></td>
<td align="center">-20.89</td>
<td align="center">0.41</td>
<td align="center">0.05</td>
<td align="center">0.30</td>
<td align="center">0.23</td>
</tr>
<tr>
<td align="left">Brain and CNS cancer</td>
<td align="center">0.006</td>
<td align="center">1.35 x 10<sup>8</sup></td>
<td align="center">0.025</td>
<td align="center">2</td>
<td align="center">2.70 x 10</td>
<td align="center">-18.73</td>
<td align="center">0.16</td>
<td align="center">0.17</td>
<td align="center">0.16</td>
<td align="center">0.17</td>
</tr>
<tr>
<td align="left">Trachea, bronchus and lung cancer</td>
<td align="center">0.066</td>
<td align="center">1.22 x 10<sup>9</sup></td>
<td align="center">0.07</td>
<td align="center">5.6</td>
<td align="center">9.27 x 10<sup>9</sup></td>
<td align="center">-11.77</td>
<td align="center">2.95</td>
<td align="center">2.02</td>
<td align="center">2.30</td>
<td align="center">2.30</td>
</tr>
<tr>
<td align="left">Melanoma</td>
<td align="center">0.021</td>
<td align="center">3.80 x 10<sup>9</sup></td>
<td align="center">2.48</td>
<td align="center">199</td>
<td align="center">7.64 x 10<sup>11</sup></td>
<td align="center">-19.94</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">Bone cancer (osteosarcoma)</td>
<td align="center">0.00035<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td>
<td align="center">4.18 x 10<sup>6</sup></td>
<td align="center">0.067</td>
<td align="center">5</td>
<td align="center">2.93 x 10<sup>7</sup></td>
<td align="center">-25.80</td>
<td align="center">1.17</td>
<td align="center">0.03</td>
<td align="center">0.83</td>
<td align="center">0.6</td>
</tr>
<tr>
<td align="left">Thyroid cancer</td>
<td align="center">0.011</td>
<td align="center">6.50 x 10<sup>7</sup></td>
<td align="center">0.087</td>
<td align="center">7</td>
<td align="center">5.85 x 10<sup>8</sup></td>
<td align="center">-17.17</td>
<td align="center">0.36</td>
<td align="center">0.8</td>
<td align="center">0.36</td>
<td align="center">0.36</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><sup>a</sup>sievert (Sv) is the weighted SI unit of radiation dose = 1 J kg<sup>-1</sup> [<xref ref-type="bibr" rid="pone.0150335.ref018">18</xref>]</p></fn>
<fn id="t001fn002"><p><sup>b</sup>based on Japanese atomic bomb survivors Life Span Study (LSS) cohort all leukemia mortality, Table 65 in UNSCEAR [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>] Annex A</p></fn>
<fn id="t001fn003"><p><sup>c</sup>taken from Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>];</p></fn>
<fn id="t001fn004"><p><sup>d</sup>non-melanoma skin cancer incidence.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0150335.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150335.t002</object-id>
<label>Table 2</label> <caption><title>Summary data on smoking-associated cancer risk and various tissue parameters, reproduced in part from Tomasetti &amp; Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] and Doll <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref015">15</xref>]</title></caption>
<alternatives>
<graphic id="pone.0150335.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Cancer type</th>
<th align="center">US lifetime natural cancer incidence [<xref ref-type="bibr" rid="pone.0150335.ref013">13</xref>]</th>
<th align="center">Number of stem cells in tissue of origin</th>
<th align="center">Numbers of divisions of each stem cell per year</th>
<th align="center">Numbers of divisions of each stem cell over life</th>
<th align="center">Number of divisions of all stem cell over lifetime</th>
<th align="center">Extra Risk Score (ERS)</th>
<th align="center">Mortality rate difference (/10<sup>5</sup> / year) current vs former smokers [<xref ref-type="bibr" rid="pone.0150335.ref015">15</xref>]</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Myeloid leukemia</td>
<td align="center">0.007</td>
<td align="center">1.35 x 10<sup>8</sup></td>
<td align="center">12</td>
<td align="center">960</td>
<td align="center">1.30 x 10<sup>11</sup></td>
<td align="center">-23.95</td>
<td align="center">-1.3</td>
</tr>
<tr>
<td align="left">Chronic lymphocytic leukemia</td>
<td align="center">0.006</td>
<td align="center">1.35 x 10<sup>8</sup></td>
<td align="center">12</td>
<td align="center">960</td>
<td align="center">1.30 x 10<sup>11</sup></td>
<td align="center">-24.69</td>
<td align="center">1.8</td>
</tr>
<tr>
<td align="left">Basal cell carcinoma</td>
<td align="center">0.3<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td>
<td align="center">5.82 x 10<sup>9</sup></td>
<td align="center">7.6</td>
<td align="center">608</td>
<td align="center">3.55 x 10<sup>12</sup></td>
<td align="center">-6.56</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">Colon cancer</td>
<td align="center">0.045</td>
<td align="center">2.00 x 10<sup>8</sup></td>
<td align="center">73</td>
<td align="center">5840</td>
<td align="center">1.17 x 10<sup>12</sup></td>
<td align="center">-16.25</td>
<td align="center">-4.1</td>
</tr>
<tr>
<td align="left">Esophageal cancer</td>
<td align="center">0.005</td>
<td align="center">8.64 x 10<sup>5</sup></td>
<td align="center">17.4</td>
<td align="center">1390</td>
<td align="center">1.20 x 10<sup>9</sup></td>
<td align="center">-20.89</td>
<td align="center">14.3</td>
</tr>
<tr>
<td align="left">Gallbladder cancer</td>
<td align="center">0.003736<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref></td>
<td align="center">1.60 x 10<sup>6</sup></td>
<td align="center">0.584</td>
<td align="center">47</td>
<td align="center">7.84 x 10<sup>7</sup></td>
<td align="center">-19.16</td>
<td align="center">0.4</td>
</tr>
<tr>
<td align="left">Brain cancer</td>
<td align="center">0.006</td>
<td align="center">1.35 x 10<sup>8</sup></td>
<td align="center">0.025</td>
<td align="center">2</td>
<td align="center">2.70 x 10<sup>8</sup></td>
<td align="center">-18.73</td>
<td align="center">-6.2</td>
</tr>
<tr>
<td align="left">Liver cancer</td>
<td align="center">0.009</td>
<td align="center">3.01 x 10<sup>9</sup></td>
<td align="center">0.9125</td>
<td align="center">88</td>
<td align="center">2.71 x 10<sup>11</sup></td>
<td align="center">-23.39</td>
<td align="center">7.9</td>
</tr>
<tr>
<td align="left">Trachea, bronchus and lung cancer</td>
<td align="center">0.066</td>
<td align="center">1.22 x 10<sup>9</sup></td>
<td align="center">0.07</td>
<td align="center">5.6</td>
<td align="center">9.27 x 10<sup>9</sup></td>
<td align="center">-11.77</td>
<td align="center">180.2</td>
</tr>
<tr>
<td align="left">Melanoma</td>
<td align="center">0.021</td>
<td align="center">3.80 x 10<sup>9</sup></td>
<td align="center">2.48</td>
<td align="center">199</td>
<td align="center">7.64 x 10<sup>11</sup></td>
<td align="center">-19.94</td>
<td align="center">3.4</td>
</tr>
<tr>
<td align="left">Pancreatic cancer</td>
<td align="center">0.015</td>
<td align="center">4.18 x 10<sup>9</sup></td>
<td align="center">1</td>
<td align="center">80</td>
<td align="center">3.43 x 10<sup>11</sup></td>
<td align="center">-21.04</td>
<td align="center">8.9</td>
</tr>
<tr>
<td align="left">Thyroid cancer</td>
<td align="center">0.011</td>
<td align="center">6.50 x 10<sup>7</sup></td>
<td align="center">0.087</td>
<td align="center">7</td>
<td align="center">5.85 x 10<sup>8</sup></td>
<td align="center">-17.17</td>
<td align="center">-0.6</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p><sup>a</sup>taken from Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>];</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0150335.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150335.t003</object-id>
<label>Table 3</label> <caption><title>Linear regression fits of model (9) to data of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]<xref ref-type="table-fn" rid="t003fn001"><sup>a</sup></xref>, and in some cases omitting tumors with short latency (leukemia, bone, thyroid).</title></caption>
<alternatives>
<graphic id="pone.0150335.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Coefficients</th>
<th align="center">Linear regression estimate (+95% CI)</th>
<th align="center"><italic>p</italic>-value</th>
<th align="center">R<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="4">Full dataset</td>
</tr>
<tr>
<td align="left"><italic>α</italic><sub>1</sub> (coefficient of ln[<italic>D</italic> / <italic>N</italic><sub>0</sub>])</td>
<td align="center">0.524 (0.281, 0.767)</td>
<td align="center">&lt;0.001</td>
<td align="center">0.646</td>
</tr>
<tr>
<td align="left"><italic>α</italic><sub>2</sub> (coefficient of ln[<italic>N</italic><sub>0</sub>])</td>
<td align="center">0.540 (0.312, 0.769)</td>
<td align="center">&lt;0.001</td>
<td align="center"/>
</tr>
<tr>
<td align="center" colspan="4">Analysis omitting tumors with short latency (leukemia, bone (osteosarcoma), thyroid)</td>
</tr>
<tr>
<td align="left"><italic>α</italic><sub>1</sub> (coefficient of ln[<italic>D</italic> / <italic>N</italic><sub>0</sub>])</td>
<td align="center">0.543 (0.207, 0.879)</td>
<td align="center">0.003</td>
<td align="center">0.473</td>
</tr>
<tr>
<td align="left"><italic>α</italic><sub>2</sub> (coefficient of ln[<italic>N</italic><sub>0</sub>])</td>
<td align="center">0.485 (0.151, 0.818)</td>
<td align="center">0.007</td>
<td align="center"/>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p><sup>a</sup>based on natural cancer risks, number of stem cells and cumulative stem-cell divisions in the second, fourth and seventh columns of Table S1 in Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>].</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0150335.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150335.t004</object-id>
<label>Table 4</label> <caption><title>Trends of linear regression model (11) fitted to radiation exposure-induced cancer incidence risk (REIC)(percent) (or log<sub>10</sub>[REIC]) with explanatory variables (a) numbers of stem-cell divisions per year (or log<sub>10</sub>[numbers of stem-cell divisions per year]), (b) log<sub>10</sub>[cumulative number of stem-cell divisions], (c) extra risk score (ERS) and (d) log<sub>10</sub>[number of stem-cells], using data of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>], as in <xref ref-type="table" rid="pone.0150335.t001">Table 1</xref>.</title></caption>
<alternatives>
<graphic id="pone.0150335.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Independent variable and model</th>
<th align="center">Cancer risk (REIC percent per Sv<xref ref-type="table-fn" rid="t004fn001"><sup>a</sup></xref> or log<sub>10</sub>[REIC percent per Sv<xref ref-type="table-fn" rid="t004fn001"><sup>a</sup></xref>]) per unit of each independent variable (<italic>α</italic><sub>1</sub>) (+95% CI)</th>
<th align="center"><italic>p</italic>-value</th>
<th align="center">Pearson / Spearman correlation coefficient</th>
<th align="center">R<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">REIC [Japan, BEIR VII weighted ERR/EAR model] vs number of stem-cell divisions per year</td>
<td align="center">0.008 (-0.018, 0.033)</td>
<td align="center">0.507</td>
<td align="center">0.239 / -0.027</td>
<td align="center">0.057</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, BEIR VII weighted ERR/EAR model]] vs log<sub>10</sub>[number of stem-cell divisions per year]</td>
<td align="center">0.033 (-0.240, 0.305)</td>
<td align="center">0.778</td>
<td align="center">0.119 / 0.143</td>
<td align="center">0.014</td>
</tr>
<tr>
<td align="left">REIC [Japan, ICRP weighted ERR/EAR model] vs number of stem-cell divisions per year</td>
<td align="center">0.008 (-0.017, 0.034)</td>
<td align="center">0.473</td>
<td align="center">0.257 / 0.064</td>
<td align="center">0.066</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ICRP weighted ERR/EAR model]] vs log<sub>10</sub>[number of stem-cell divisions per year]</td>
<td align="center">0.044 (-0.231, 0.320)</td>
<td align="center">0.707</td>
<td align="center">0.159 / 0.262</td>
<td align="center">0.025</td>
</tr>
<tr>
<td align="left">REIC [Japan, ERR model] vs number of stem-cell divisions per year</td>
<td align="center">0.005 (-0.028, 0.038)</td>
<td align="center">0.740</td>
<td align="center">0.120 / 0.070</td>
<td align="center">0.015</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ERR model]] vs log<sub>10</sub>[number of stem-cell divisions per year]</td>
<td align="center">0.010 (-0.296, 0.317)</td>
<td align="center">0.938</td>
<td align="center">0.033 / 0.262</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">REIC [Japan, EAR model] vs number of stem-cell divisions per year</td>
<td align="center">0.009 (-0.015, 0.033)</td>
<td align="center">0.388</td>
<td align="center">0.307 / 0.088</td>
<td align="center">0.094</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, EAR model]] vs log<sub>10</sub>[number of stem-cell divisions per year]</td>
<td align="center">0.085 (-0.396, 0.567)</td>
<td align="center">0.680</td>
<td align="center">0.174 / 0.310</td>
<td align="center">0.030</td>
</tr>
<tr>
<td align="left">REIC [Japan, BEIR VII weighted ERR/EAR model] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">-0.011 (-0.345, 0.322)</td>
<td align="center">0.939</td>
<td align="center">-0.028 / -0.076</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, BEIR VII weighted ERR/EAR model]] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">0.051 (-0.151, 0.253)</td>
<td align="center">0.560</td>
<td align="center">0.244 / 0.214</td>
<td align="center">0.060</td>
</tr>
<tr>
<td align="left">REIC [Japan, ICRP weighted ERR/EAR model] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">0.024 (-0.310,0.359)</td>
<td align="center">0.870</td>
<td align="center">0.060 / 0.076</td>
<td align="center">0.004</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ICRP weighted ERR/EAR model]] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">0.082 (-0.113, 0.277)</td>
<td align="center">0.343</td>
<td align="center">0.387 / 0.452</td>
<td align="center">0.150</td>
</tr>
<tr>
<td align="left">REIC [Japan, ERR model] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">-0.068 (-0.485, 0.350)</td>
<td align="center">0.717</td>
<td align="center">-0.131 / -0.137</td>
<td align="center">0.017</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ERR model]] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">0.012 (-0.221, 0.244)</td>
<td align="center">0.907</td>
<td align="center">0.050 / 0.143</td>
<td align="center">0.002</td>
</tr>
<tr>
<td align="left">REIC [Japan, EAR model] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">0.084 (-0.229, 0.397)</td>
<td align="center">0.553</td>
<td align="center">0.214 / 0.149</td>
<td align="center">0.046</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, EAR model]] vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">0.244 (-0.035, 0.523)</td>
<td align="center">0.077</td>
<td align="center">0.657 / 0.595</td>
<td align="center">0.432</td>
</tr>
<tr>
<td align="left">REIC [Japan, BEIR VII weighted ERR/EAR model] vs extra risk score</td>
<td align="center">0.043 (-0.052, 0.138)</td>
<td align="center">0.327</td>
<td align="center">0.346 / 0.340</td>
<td align="center">0.120</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, BEIR VII weighted ERR/EAR model]] vs extra risk score</td>
<td align="center">0.005 (-0.059, 0.068)</td>
<td align="center">0.867</td>
<td align="center">0.071 / 0.214</td>
<td align="center">0.005</td>
</tr>
<tr>
<td align="left">REIC [Japan, ICRP weighted ERR/EAR model] vs extra risk score</td>
<td align="center">0.051 (-0.042, 0.144)</td>
<td align="center">0.240</td>
<td align="center">0.410 / 0.413</td>
<td align="center">0.168</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ICRP weighted ERR/EAR model]] vs extra risk score</td>
<td align="center">0.014 (-0.050, 0.077)</td>
<td align="center">0.618</td>
<td align="center">0.210 / 0.333</td>
<td align="center">0.044</td>
</tr>
<tr>
<td align="left">REIC [Japan, ERR model] vs extra risk score</td>
<td align="center">0.044 (-0.079, 0.167)</td>
<td align="center">0.432</td>
<td align="center">0.281 / 0.207</td>
<td align="center">0.079</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ERR model]] vs extra risk score</td>
<td align="center">-0.006 (-0.078, 0.065)</td>
<td align="center">0.833</td>
<td align="center">-0.089 / 0.000</td>
<td align="center">0.008</td>
</tr>
<tr>
<td align="left">REIC [Japan, EAR model] vs extra risk score</td>
<td align="center">0.069 (-0.010, 0.148)</td>
<td align="center">0.079</td>
<td align="center">0.580 / 0.681</td>
<td align="center">0.336</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, EAR model]] vs extra risk score</td>
<td align="center">0.074 (-0.012, 0.161)</td>
<td align="center">0.080</td>
<td align="center">0.652 / 0.667</td>
<td align="center">0.425</td>
</tr>
<tr>
<td align="left">REIC [Japan, BEIR VII weighted ERR/EAR model] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.299 (-0.421, 0.547)</td>
<td align="center">0.773</td>
<td align="center">0.105 / -0.006</td>
<td align="center">0.011</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, BEIR VII weighted ERR/EAR model]] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.509 (-0.239, 0.364)</td>
<td align="center">0.629</td>
<td align="center">0.204 / 0.311</td>
<td align="center">0.041</td>
</tr>
<tr>
<td align="left">REIC [Japan, ICRP weighted ERR/EAR model] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.110 (-0.370, 0.590)</td>
<td align="center">0.612</td>
<td align="center">0.184 / 0.117</td>
<td align="center">0.034</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ICRP weighted ERR/EAR model]] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.118 (-0.173, 0.408)</td>
<td align="center">0.360</td>
<td align="center">0.375 / 0.491</td>
<td align="center">0.140</td>
</tr>
<tr>
<td align="left">REIC [Japan, ERR model] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.039 (-0.575, 0.652)</td>
<td align="center">0.888</td>
<td align="center">0.051 / -0.142</td>
<td align="center">0.003</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, ERR model]] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.003 (-0.341, 0.347)</td>
<td align="center">0.983</td>
<td align="center">0.009 / 0.096</td>
<td align="center">0.000</td>
</tr>
<tr>
<td align="left">REIC [Japan, EAR model] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.197 (-0.242, 0.636)</td>
<td align="center">0.330</td>
<td align="center">0.344 / 0.215</td>
<td align="center">0.118</td>
</tr>
<tr>
<td align="left">log<sub>10</sub>[REIC [Japan, EAR model]] vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">0.425 (0.078, 0.772)</td>
<td align="center">0.024</td>
<td align="center">0.775 / 0.659</td>
<td align="center">0.600</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p><sup>a</sup>sievert (Sv) is the weighted SI unit of radiation dose = 1 J kg<sup>-1</sup> [<xref ref-type="bibr" rid="pone.0150335.ref018">18</xref>]</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0150335.t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150335.t005</object-id>
<label>Table 5</label> <caption><title>Trends of linear regression model (12) fitted to mortality rate difference [current smokers–former smokers] (/10<sup>5</sup> /year) with explanatory variables (a) numbers of stem-cell divisions per year, (b) log<sub>10</sub>[cumulative number of stem-cell divisions], (c) extra risk score (ERS) and (d) log<sub>10</sub>[number of stem-cells], using data of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>], as in <xref ref-type="table" rid="pone.0150335.t002">Table 2</xref>.</title></caption>
<alternatives>
<graphic id="pone.0150335.t005g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.t005" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Independent variable and model</th>
<th align="center">Cancer risk (mortality rate difference [current–former smokers] / 10<sup>5</sup> / year) per unit of each independent variable (<italic>α</italic><sub>1</sub>) (+95% CI)</th>
<th align="center"><italic>p</italic>-value</th>
<th align="center">Pearson / Spearman correlation coefficient</th>
<th align="center">R<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Smoking cancer risk vs number of stem-cell divisions per year</td>
<td align="center">-0.469 (-2.212, 1.274)</td>
<td align="center">0.562</td>
<td align="center">-0.186 / -0.035</td>
<td align="center">0.035</td>
</tr>
<tr>
<td align="left">Smoking cancer risk vs log<sub>10</sub>[number of stem-cell divisions per year]</td>
<td align="center">-17.715 (-49.015, 13.585)</td>
<td align="center">0.236</td>
<td align="center">-0.370 / -0.035</td>
<td align="center">0.137</td>
</tr>
<tr>
<td align="left">Smoking cancer risk vs log<sub>10</sub>[cumulative number of stem-cell divisions]</td>
<td align="center">-3.095 (-25.972, 19.782)</td>
<td align="center">0.769</td>
<td align="center">-0.095 / 0.042</td>
<td align="center">0.009</td>
</tr>
<tr>
<td align="left">Smoking cancer risk vs extra risk score</td>
<td align="center">3.741 (-2.702, 10.185)</td>
<td align="center">0.225</td>
<td align="center">0.379 / -0.182</td>
<td align="center">0.143</td>
</tr>
<tr>
<td align="left">Smoking cancer risk vs log<sub>10</sub>[number of stem cells]</td>
<td align="center">6.957 (-21.246, 35.160)</td>
<td align="center">0.595</td>
<td align="center">0.171 / 0.169</td>
<td align="center">0.029</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="pone.0150335.t006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0150335.t006</object-id>
<label>Table 6</label> <caption><title>Trends of linear regression model (13) of log<sub>10</sub>[US lifetime natural cancer incidence risk] vs log<sub>10</sub>[cumulative stem-cell divisions]among cancer sites with available radiation risk (<xref ref-type="table" rid="pone.0150335.t001">Table 1</xref>) or smoking risk (<xref ref-type="table" rid="pone.0150335.t002">Table 2</xref>) data, and in the dataset of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>], and in some cases omitting tumors with short latency (leukemia, bone, thyroid).</title></caption>
<alternatives>
<graphic id="pone.0150335.t006g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.t006" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Natural cancer dataset used</th>
<th align="center">log<sub>10</sub>[US lifetime natural cancer incidence risk] per unit of log<sub>10</sub>[cumulative stem-cell divisions] (<italic>α</italic><sub>1</sub>) (+95% CI)</th>
<th align="center"><italic>p</italic>-value</th>
<th align="center">Pearson / Spearman correlation coefficient</th>
<th align="center">R<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="5">Full dataset</td>
</tr>
<tr>
<td align="left">Radiation data natural cancer risks (<xref ref-type="table" rid="pone.0150335.t001">Table 1</xref>)<xref ref-type="table-fn" rid="t006fn001"><sup>a</sup></xref></td>
<td align="center">0.349 (0.117, 0.580)</td>
<td align="center">0.009</td>
<td align="center">0.775 / 0.771</td>
<td align="center">0.600</td>
</tr>
<tr>
<td align="left">Smoking data natural cancer risks (<xref ref-type="table" rid="pone.0150335.t002">Table 2</xref>)<xref ref-type="table-fn" rid="t006fn002"><sup>b</sup></xref></td>
<td align="center">0.214 (0.017, 0.412)</td>
<td align="center">0.036</td>
<td align="center">0.608 / 0.732</td>
<td align="center">0.369</td>
</tr>
<tr>
<td align="left">Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] data natural cancer risks <xref ref-type="table-fn" rid="t006fn003"><sup>c</sup></xref></td>
<td align="center">0.533 (0.383, 0.682)</td>
<td align="center">&lt;0.001</td>
<td align="center">0.804 / 0.810</td>
<td align="center">0.646</td>
</tr>
<tr>
<td align="center" colspan="5">Analysis omitting tumors with short latency (leukemia, bone (osteosarcoma), thyroid)</td>
</tr>
<tr>
<td align="left">Radiation data natural cancer risks (<xref ref-type="table" rid="pone.0150335.t001">Table 1</xref>)<xref ref-type="table-fn" rid="t006fn001"><sup>a</sup></xref></td>
<td align="center">0.300 (-0.043, 0.643)</td>
<td align="center">0.072</td>
<td align="center">0.772 / 0.771</td>
<td align="center">0.596</td>
</tr>
<tr>
<td align="left">Smoking data natural cancer risks (<xref ref-type="table" rid="pone.0150335.t002">Table 2</xref>)<xref ref-type="table-fn" rid="t006fn002"><sup>b</sup></xref></td>
<td align="center">0.256 (0.031, 0.481)</td>
<td align="center">0.031</td>
<td align="center">0.713 / 0.817</td>
<td align="center">0.509</td>
</tr>
<tr>
<td align="left">Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] data natural cancer risks <xref ref-type="table-fn" rid="t006fn003"><sup>c</sup></xref></td>
<td align="center">0.513 (0.260, 0.767)</td>
<td align="center">&lt;0.001</td>
<td align="center">0.686 / 0.725</td>
<td align="center">0.832</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t006fn001"><p><sup>a</sup>based on natural cancer risks and cumulative stem-cell divisions in the second and sixth columns of <xref ref-type="table" rid="pone.0150335.t001">Table 1</xref>;</p></fn>
<fn id="t006fn002"><p><sup>b</sup>based on natural cancer risks and cumulative stem-cell divisions in the second and sixth columns of <xref ref-type="table" rid="pone.0150335.t002">Table 2</xref>;</p></fn>
<fn id="t006fn003"><p><sup>c</sup>based on natural cancer risks and cumulative stem-cell divisions in the second and seventh columns of Table S1 in Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>].</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec007">
<title>Methods and Data</title>
<p>We tested the prediction of expression (6) via regression of the logarithm of the lifetime natural cancer risk, ln[<italic>CR</italic>], in relation to the log of the number of cell divisions per stem cell, ln[<italic>D</italic> / <italic>N</italic><sub>0</sub>] and the log of the number of stem cells, ln[<italic>N</italic><sub>0</sub>]. Specifically we fitted a model in which the log of the lifetime cancer risk is assumed to be given by:
<disp-formula id="pone.0150335.e009">
<alternatives>
<graphic id="pone.0150335.e009g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e009" xlink:type="simple"/>
<mml:math display="block" id="M9">
<mml:mrow><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>C</mml:mi><mml:mi>R</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.15em"/><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>D</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mspace width="0.15em"/><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo><mml:mo>+</mml:mo><mml:mi>ε</mml:mi></mml:mrow>
</mml:math>
</alternatives>
<label>(9)</label>
</disp-formula></p>
<p>The data used is drawn from Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>], subject to minor alterations, relating to the entries for glioblastoma and medulloblastoma; the number of divisions per stem cell (over a lifetime) was derived by dividing the cumulative number of stem-cell divisions by the total number of stem cells. The number of divisions per stem cell per year was derived from this figure by dividing by 80 (the approximate mean lifetime, in years).</p>
<p>Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] assess the extra-risk score (ERS), given by:
<disp-formula id="pone.0150335.e010">
<alternatives>
<graphic id="pone.0150335.e010g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e010" xlink:type="simple"/>
<mml:math display="block" id="M10">
<mml:mrow><mml:mi>E</mml:mi><mml:mi>R</mml:mi><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mtext>ln</mml:mtext></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>C</mml:mi><mml:mi>R</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:msub><mml:mrow><mml:mtext>ln</mml:mtext></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(10)</label>
</disp-formula></p>
<p>It should be noted that <italic>CR</italic>, being a probability, is always less than or equal to 1, and <italic>D</italic> is usually substantially greater than 1, as shown in Tables <xref ref-type="table" rid="pone.0150335.t001">1</xref> and <xref ref-type="table" rid="pone.0150335.t002">2</xref>, so that <italic>ERS</italic> will almost always be negative. Tomasetti and Vogelstein used an adjusted ERS measure, defined as <italic>ERS</italic> + 18.49; the figure 18.49 was derived from a <italic>K</italic>-means clustering analysis [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]. [<underline>Note:</underline> we shall retain the original definition of ERS given by Eq (<xref ref-type="disp-formula" rid="pone.0150335.e010">10</xref>)–adding a constant makes no difference to any statistical inference using it.] They speculated that “if the ERS for a tissue type is high–that is, if there is a high cancer risk of that tissue type relative to its number of stem-cell divisions—then one would expect that environmental or inherited factors would play a relatively more important role in that cancer’s risk” [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]. For most of the analysis of Tables <xref ref-type="table" rid="pone.0150335.t004">4</xref>–<xref ref-type="table" rid="pone.0150335.t006">6</xref> we re-estimated <italic>CR</italic> for each cancer site, using baseline US cancer risks [<xref ref-type="bibr" rid="pone.0150335.ref013">13</xref>], rather than using the estimates given by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]; only for the analysis in the bottom row in <xref ref-type="table" rid="pone.0150335.t006">Table 6</xref> are the original cancer risks of Tomasetti and Vogelstein employed. For this reason the ERS for various endpoints is re-calculated using Eq (<xref ref-type="disp-formula" rid="pone.0150335.e010">10</xref>), rather than using the values employed by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]. The re-estimated values <italic>CR</italic> and ERS are given in Tables <xref ref-type="table" rid="pone.0150335.t001">1</xref> and <xref ref-type="table" rid="pone.0150335.t002">2</xref>.</p>
<p>A test can be made of the assumption of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] that ERS may be correlated with the variation in susceptibility of a tissue to environmental factors, using radiation-associated and smoking-associated cancer risk as examples of such factors, both mutagens that induce a large number of types of cancer [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0150335.ref015">15</xref>]. We considered radiation-exposure induced cancer incidence risk (REIC) evaluated by the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) [Table 70 in Annex A of [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>]] for various cancer sites, as shown in <xref ref-type="table" rid="pone.0150335.t001">Table 1</xref>; for leukemia we use radiation-exposure induced cancer death risk (REID) evaluated by UNSCEAR [Table 65 in Annex A of [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>]]; mortality was used because leukemia incidence was not evaluated in the latest LSS cancer incidence report [<xref ref-type="bibr" rid="pone.0150335.ref016">16</xref>], a preliminary version of which formed the basis of the UNSCEAR evaluations [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>]. This we do by fitting a model in which:
<disp-formula id="pone.0150335.e011">
<alternatives>
<graphic id="pone.0150335.e011g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e011" xlink:type="simple"/>
<mml:math display="block" id="M11">
<mml:mrow><mml:mi>R</mml:mi><mml:mi>E</mml:mi><mml:mi>I</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:mi>R</mml:mi><mml:mi>S</mml:mi><mml:mo>+</mml:mo><mml:mi>ε</mml:mi></mml:mrow>
</mml:math>
</alternatives>
<label>(11)</label>
</disp-formula></p>
<p>Similar models were fitted replacing the explanatory (independent) variable, <italic>ERS</italic>, by any of: (a) the cumulative number of stem-cell divisions over lifetime; (b) the number of stem-cell divisions per year; or (c) the number of stem cells, as we discuss below. From now on, in Eq (<xref ref-type="disp-formula" rid="pone.0150335.e011">11</xref>) and subsequent discussions it is to be understood that REIC is replaced by REID whenever appropriate (i.e., for leukemia). We are most interested here in the parameter <italic>α</italic><sub>1</sub>, the change in REIC per unit of <italic>ERS</italic>. The measures of REIC or REID are those estimated using a generalized absolute risk or generalized relative risk model fitted to current Japanese atomic bomb survivor data by UNSCEAR [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>]. The cancer incidence [<xref ref-type="bibr" rid="pone.0150335.ref016">16</xref>] and mortality [<xref ref-type="bibr" rid="pone.0150335.ref017">17</xref>] data derived from the Japanese atomic bomb survivor Life Span Study (LSS) cohort are the primary basis for most sets of risk estimates obtained by national and international radiation safety committees, such as the International Commission on Radiological Protection (ICRP) [<xref ref-type="bibr" rid="pone.0150335.ref018">18</xref>], UNSCEAR [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>], and the Biological Effects of Ionizing Radiation (BEIR) committee [<xref ref-type="bibr" rid="pone.0150335.ref019">19</xref>]. There is considerable uncertainty as to how one should transfer radiation risk estimates between populations. We have used lifetime population risk estimates for a current population that is as close as possible to the LSS cohort, namely the Japanese population. However, even in this case it is not clear how one transfers risk from the wartime-exposed LSS cohort, subject to a variety of privations, to a current Japanese population [<xref ref-type="bibr" rid="pone.0150335.ref020">20</xref>]. The two most common methods of transfer are based on risk models expressed in terms of the excess relative risk (ERR) or the excess absolute risk (EAR) produced by exposure to ionizing radiation during the atomic bombings. The use of the terms ERR and EAR in this context is slightly misleading, as most scientific committees [<xref ref-type="bibr" rid="pone.0150335.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0150335.ref019">19</xref>] have developed models of relative and absolute excess risk with adjustment for attained age, age at exposure and other risk-modifying variables. Risk transfer is often assumed to be intermediate between additive (i.e., based on EAR models) or multiplicative (i.e., based on ERR models) [<xref ref-type="bibr" rid="pone.0150335.ref020">20</xref>], and ICRP [<xref ref-type="bibr" rid="pone.0150335.ref018">18</xref>] and BEIR [<xref ref-type="bibr" rid="pone.0150335.ref019">19</xref>] have developed independent cancer-site-specific weighting schemes for the contributions made by the EAR and ERR models. For this reason, we have used both REIC based on both of these (ICRP [<xref ref-type="bibr" rid="pone.0150335.ref018">18</xref>], BEIR [<xref ref-type="bibr" rid="pone.0150335.ref019">19</xref>]) schemes in <xref ref-type="table" rid="pone.0150335.t004">Table 4</xref>, as well as those based on pure EAR or ERR transfer.</p>
<p>Likewise, we assess the correlations of smoking-associated cancer risk using data on differences in mortality rates between current and former smokers, <italic>Sm</italic><sub><italic>diff</italic></sub>, in the British doctors’ cohort [<xref ref-type="bibr" rid="pone.0150335.ref015">15</xref>], as shown in <xref ref-type="table" rid="pone.0150335.t002">Table 2</xref>, fitting a model in which:
<disp-formula id="pone.0150335.e012">
<alternatives>
<graphic id="pone.0150335.e012g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e012" xlink:type="simple"/>
<mml:math display="block" id="M12">
<mml:mrow><mml:mi>S</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:mi>R</mml:mi><mml:mi>S</mml:mi><mml:mo>+</mml:mo><mml:mi>ε</mml:mi></mml:mrow>
</mml:math>
</alternatives>
<label>(12)</label>
</disp-formula></p>
<p>We are most interested here in the parameter <italic>α</italic><sub>1</sub>, the change in <italic>Sm</italic><sub><italic>diff</italic></sub> per unit of <italic>ERS</italic>. We tested the correlations of site-specific cancer risk with:</p>
<list list-type="order">
<list-item><p>number of stem-cell divisions per year (or log<sub>10</sub>[number of stem-cell divisions per year]);</p></list-item>
<list-item><p>log<sub>10</sub>[cumulative number of stem-cell divisions over lifetime];</p></list-item>
<list-item><p>ERS; and</p></list-item>
<list-item><p>log<sub>10</sub>[total number of stem cells].</p></list-item>
</list>
<p>Tests for association were performed by fitting linear models with dependent measures:</p>
<list list-type="order">
<list-item><p>REIC (percent Sv<sup>-1</sup>) (or log<sub>10</sub>[REIC]); and</p></list-item>
<list-item><p>difference between mortality rate (per 10<sup>5</sup> per year) for current smokers and former smokers in the British doctors’ cohort [<xref ref-type="bibr" rid="pone.0150335.ref015">15</xref>].</p></list-item>
</list>
<p>Finally, we judged it important to assess the effect of selection of cancer sites involved in selecting radiation-associated and tobacco-associated risk. Tables <xref ref-type="table" rid="pone.0150335.t001">1</xref> and <xref ref-type="table" rid="pone.0150335.t002">2</xref> represent a selected subset of the 31 cancer sites considered by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>], namely those with data on radiation or smoking risk, numbering 10 and 12 endpoints respectively. As such it is possible that we may have inadvertently selected cancers that have a different pattern of risk. To test this possibility, we fitted a linear regression model of log<sub>10</sub>[lifetime cancer incidence risk], in relation to log<sub>10</sub>[cumulative stem-cell divisions] to these two subsets, as well as the original Tomasetti and Vogelstein data, via the model:
<disp-formula id="pone.0150335.e013">
<alternatives>
<graphic id="pone.0150335.e013g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e013" xlink:type="simple"/>
<mml:math display="block" id="M13">
<mml:mrow><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>C</mml:mi><mml:mi>R</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.1em"/><mml:mtext>ln</mml:mtext><mml:mo stretchy="false">[</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>+</mml:mo><mml:mi>ε</mml:mi></mml:mrow>
</mml:math>
</alternatives>
<label>(13)</label>
</disp-formula></p>
<p>We are most interested here in the parameter <italic>α</italic><sub>1</sub>, the change in ln[<italic>CR</italic>] per unit of ln[<italic>D</italic>].</p>
<p>Because of the possibility of heterogeneity in the types of tumor being considered, and in particular differences between tumors in the number of driver mutations, for certain sensitivity analyses (Tables <xref ref-type="table" rid="pone.0150335.t003">3</xref> and <xref ref-type="table" rid="pone.0150335.t006">6</xref> and Tables A and B in <xref ref-type="supplementary-material" rid="pone.0150335.s001">S1 Text</xref>) we evaluated model fits restricting to those common epithelial sites that were judged to have a rather larger number of critical driver mutations, specifically omitting three cancer types (leukemia, bone cancer (osteosarcoma), thyroid cancer) that appear to have a shorter latency of induction after radiation exposure [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>].</p>
<p>All linear regressions were performed via ordinary least squares [<xref ref-type="bibr" rid="pone.0150335.ref021">21</xref>], using R [<xref ref-type="bibr" rid="pone.0150335.ref022">22</xref>]. The <italic>p</italic>-values shown in Tables <xref ref-type="table" rid="pone.0150335.t004">4</xref>–<xref ref-type="table" rid="pone.0150335.t006">6</xref> were generally estimated using an <italic>F</italic>-test [<xref ref-type="bibr" rid="pone.0150335.ref021">21</xref>], and are in relation to the respective trend parameters (<italic>α</italic><sub>1</sub>, <italic>α</italic><sub>2</sub>). In <xref ref-type="table" rid="pone.0150335.t003">Table 3</xref> the <italic>p</italic>-values for each parameter (<italic>α</italic><sub>1</sub>, <italic>α</italic><sub>2</sub>) were estimated using a 2-sided <italic>t</italic>-test [<xref ref-type="bibr" rid="pone.0150335.ref021">21</xref>]. The data on stem cell turnover used (Tables <xref ref-type="table" rid="pone.0150335.t001">1</xref> and <xref ref-type="table" rid="pone.0150335.t002">2</xref>) are largely taken from Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] (with minor modifications for glioblastoma as indicated above). However, for the purposes of fitting models (11) and (12) we employed slightly different estimates of lifetime cancer risk [<xref ref-type="bibr" rid="pone.0150335.ref013">13</xref>], and correspondingly modified estimates of ERS, derived via expression (10).</p>
</sec>
<sec id="sec008" sec-type="results">
<title>Results</title>
<p><xref ref-type="table" rid="pone.0150335.t003">Table 3</xref> details the fit of model (6), and indicates that the power of <italic>D</italic> / <italic>N</italic><sub>0</sub> (adjusted for <italic>N</italic><sub>0</sub>) is <italic>α</italic><sub>1</sub> = 0.524 (95% CI 0.281, 0.767), and the power of <italic>N</italic><sub>0</sub> (adjusted for <italic>D</italic> / <italic>N</italic><sub>0</sub>) is <italic>α</italic><sub>2</sub> = 0.540 (95% CI 0.312, 0.769), i.e., both <italic>α</italic><sub>1</sub> and <italic>α</italic><sub>2</sub> are considerably less than 1. The Table shows that the analyses are essentially unchanged if those tumors with short latency (leukemia, bone, thyroid) are omitted from the analysis.</p>
<p>Tables <xref ref-type="table" rid="pone.0150335.t004">4</xref> and <xref ref-type="table" rid="pone.0150335.t005">5</xref> and Figures A and B in <xref ref-type="supplementary-material" rid="pone.0150335.s004">S4 Text</xref> show that there is no evidence of associations (<italic>p</italic>&gt;0.05) of any of these measures (number of stem-cell divisions per year, log<sub>10</sub>[cumulative number of stem-cell divisions over lifetime], ERS, log<sub>10</sub>[number of stem cells]) with REIC or smoking mortality rate difference, regardless of the model used. There are borderline-significant increasing trends of various measures of radiation risk, specifically log<sub>10</sub>[REIC] with log<sub>10</sub>[cumulative number of stem-cell divisions] (<italic>p</italic> = 0.077), REIC with ERS (<italic>p</italic> = 0.079) and log<sub>10</sub>[REIC] with log<sub>10</sub>[number of stem cells] (<italic>p</italic> = 0.024) (<xref ref-type="table" rid="pone.0150335.t004">Table 4</xref>), and these models are also the only ones with R<sup>2</sup>&gt;0.2, although generally weaker trends (<italic>p</italic>&gt;0.2) and smaller R<sup>2</sup> (&lt;0.2) are observed with risks estimated using the BEIR VII or ICRP weighted EAR/ERR models. The analyses are essentially unchanged if those tumors with short latency (leukemia, bone, thyroid) are omitted from the analysis (Tables A and B in <xref ref-type="supplementary-material" rid="pone.0150335.s001">S1 Text</xref>), although no trends approach statistical significance (<italic>p</italic>&gt;0.1) and most R<sup>2</sup> are small (all but four are &lt;0.2).</p>
<p>The results of fitting model (13), reported in <xref ref-type="table" rid="pone.0150335.t006">Table 6</xref>, suggests that there are significant (<italic>p</italic> = 0.009) trends of log<sub>10</sub>[lifetime natural cancer incidence risk] vs unit of log<sub>10</sub>[cumulative stem-cell divisions] in the set of 10 radiation-cancer sites (<xref ref-type="table" rid="pone.0150335.t001">Table 1</xref>), as also (<italic>p</italic> = 0.036) in the set of 12 tobacco-cancer sites (<xref ref-type="table" rid="pone.0150335.t002">Table 2</xref>). <xref ref-type="table" rid="pone.0150335.t006">Table 6</xref> also shows that the analyses are essentially unchanged if those tumors with short latency (leukemia, bone, thyroid) are omitted from the analysis.</p>
</sec>
<sec id="sec009" sec-type="conclusions">
<title>Discussion</title>
<p>As outlined in the Introduction, one would expect cancer rate to be proportional to the <italic>k</italic>th power of the expected number of cell divisions per stem cell, with <italic>k</italic> in the range 5–7 as implied by the shape of the age-incidence relationship for most cancers [<xref ref-type="bibr" rid="pone.0150335.ref003">3</xref>]. By expression (6) this implies that the cancer rate should be proportional to a power of the expected number of divisions per stem cell, in other words proportional to <inline-formula id="pone.0150335.e014"><alternatives><graphic id="pone.0150335.e014g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e014" xlink:type="simple"/><mml:math display="inline" id="M14"><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>D</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> with <italic>F</italic>((<italic>g</italic><sub><italic>i</italic></sub>),<italic>k</italic>) between 3.08 and 3.45. We have shown that the cancer rate is proportional to a power of the expected number of divisions per stem cell with 95% upper CI that is less than 0.8 (<xref ref-type="table" rid="pone.0150335.t003">Table 3</xref>), about a quarter of the lower limit of the suggested range, 3.08, implying some inconsistency with the age-incidence relationship and the predictions of a multistage carcinogenesis model, if one makes the strong assumption of homogeneity of numbers of driver mutations across cancer sites, which we discuss below. Analysis of ERS and various other measures considered by Tomasetti and Vogelstein suggests that these are poorly predictive of radiation- or smoking-associated cancer risk (Tables <xref ref-type="table" rid="pone.0150335.t004">4</xref> and <xref ref-type="table" rid="pone.0150335.t005">5</xref>). There is weak evidence at a marginal levels of statistical significance (<italic>p</italic> = 0.024–0.080) of trend for four measures, two in relation to ERS, one in relation to cumulative stem-cell divisions, and one in relation to number of stem cells (<xref ref-type="table" rid="pone.0150335.t004">Table 4</xref>). However, the probability of four or more independent events out of the 37 tested trends in Tables <xref ref-type="table" rid="pone.0150335.t004">4</xref> and <xref ref-type="table" rid="pone.0150335.t005">5</xref>, each with probability <italic>p</italic>, is <inline-formula id="pone.0150335.e015"><alternatives><graphic id="pone.0150335.e015g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e015" xlink:type="simple"/><mml:math display="inline" id="M15"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>37</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mn>37</mml:mn><mml:mi>p</mml:mi><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>36</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mn>37</mml:mn><mml:mo>⋅</mml:mo><mml:mn>36</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>⋅</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:msup><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>35</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mn>37</mml:mn><mml:mo>⋅</mml:mo><mml:mn>36</mml:mn><mml:mo>⋅</mml:mo><mml:mn>35</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>⋅</mml:mo><mml:mn>2</mml:mn><mml:mo>⋅</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:msup><mml:mi>p</mml:mi><mml:mn>3</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>34</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, which takes the value 0.218 when the mean <italic>p</italic>-value of these four, <italic>p</italic> = 0.065, is substituted. If the 37 non-significant (<italic>p</italic>&gt;0.1) trends in Tables A and B in <xref ref-type="supplementary-material" rid="pone.0150335.s001">S1 Text</xref> are included in this total then the analogous calculation is <inline-formula id="pone.0150335.e016"><alternatives><graphic id="pone.0150335.e016g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0150335.e016" xlink:type="simple"/><mml:math display="inline" id="M16"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>74</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mn>74</mml:mn><mml:mi>p</mml:mi><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>73</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mn>74</mml:mn><mml:mo>⋅</mml:mo><mml:mn>73</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>⋅</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:msup><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>72</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mn>74</mml:mn><mml:mo>⋅</mml:mo><mml:mn>73</mml:mn><mml:mo>⋅</mml:mo><mml:mn>72</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>⋅</mml:mo><mml:mn>2</mml:mn><mml:mo>⋅</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:msup><mml:mi>p</mml:mi><mml:mn>3</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>71</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, which takes the value 0.716 when the mean <italic>p</italic>-value of <italic>p</italic> = 0.065 is substituted. These results do not therefore suggest anything other than chance findings.</p>
<p>Tomasetti and Vogelstein performed additional analysis, correlating lifetime number of stem cell divisions or total number of stem cells with data on the EAR or ERR at exposure age 30, taken from Table 11 of Preston <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref016">16</xref>], described in a somewhat summarial way in an online technical report [<xref ref-type="bibr" rid="pone.0150335.ref023">23</xref>]. Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref023">23</xref>] observed no correlation between lifetime number of stem cell divisions, or total number of stem cells, and radiation-associated EAR or ERR, to some extent paralleling our findings. Tomasetti and Vogelstein argue that this absence of correlation implies that “the correlation … found between cancer risk and total number of stem cell divisions is not due to the effects of environmental factors, but rather to replicative mutations” [<xref ref-type="bibr" rid="pone.0150335.ref023">23</xref>]. Their later analysis takes no account of the fact that there is not a single number that describes radiation-associated ERR or EAR, which for most cancer sites are strongly modified by age at exposure, and attained age, as is clear in any case from Preston <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref016">16</xref>], and from much other data [<xref ref-type="bibr" rid="pone.0150335.ref014">14</xref>]. Using only a single number for ERR or EAR, for exposure age 30 for each cancer site is therefore somewhat arbitrary, and does not adequately take account of the lifetime radiation-associated cancer risk, which we judge to be the more legitimate quantity; in the present paper we have assessed these radiation-associated risks in a number of ways, via REIC and REID. There has been no parallel analysis of smoking data by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref023">23</xref>], so that in any case most of the analysis we have done, reported in Tables <xref ref-type="table" rid="pone.0150335.t003">3</xref>–<xref ref-type="table" rid="pone.0150335.t005">5</xref> and Tables A and B in <xref ref-type="supplementary-material" rid="pone.0150335.s001">S1 Text</xref>, looking not simply at lifetime number of stem cell divisions or numbers of stem cells, but also number of stem-cell divisions per year and logarithmic transformations of these measures, is not paralleled in this online report [<xref ref-type="bibr" rid="pone.0150335.ref023">23</xref>].</p>
<p>It might be inferred from the use that Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] make of logarithmically transformed variables (e.g., lifetime cancer risk, total stem cell divisions) in their analysis that relative risk would be the most relevant measure with which to assess “extrinsic” environmentally-driven and “intrinsic” cell-replication driven risk. However, as is clear from <xref ref-type="table" rid="pone.0150335.t004">Table 4</xref> there is little difference made whether one uses relative risk models, absolute risk models or some mixture of the two for evaluating lifetime radiation risk.</p>
<p>A notable recent paper of Wu <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref024">24</xref>] reanalyzed the data of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]. Their analysis, combined with insights gained from a mathematical cancer model that they developed, suggested that “intrinsic [non-replicative] factors contribute only modestly (less than ~10–30% of lifetime risk) to cancer development”, a strikingly different assessment from that made by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>].</p>
<p>A critical assumption in our analysis of the power-age relationship is that the underlying process is describable by the multistage model of Armitage and Doll, with a constant number of driver mutation stages <italic>k</italic>. This implies that the incidence at age <italic>t</italic> a power of age is approximately <italic>CN</italic><sub>0</sub><italic>t</italic><sup><italic>k</italic>−1</sup> [<xref ref-type="bibr" rid="pone.0150335.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0150335.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0150335.ref011">11</xref>]. While this is the case for most cancers considered here, with a range of the exponent <italic>k</italic> between 5 and 7 [<xref ref-type="bibr" rid="pone.0150335.ref003">3</xref>], it is certainly not the case for certain pediatric tumors, in particular acute lymphocytic leukemia, which is not one of the tumors considered by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]. One possible way in which our analysis might underestimate the slope of the relationship between ln[cancer risk] and ln[stem-cell divisions per stem cell] (i.e. ln[<italic>D</italic> / <italic>N</italic><sub>0</sub>]), which by the expression (6) corresponds to <italic>F</italic>((<italic>g</italic><sub><italic>i</italic></sub>),<italic>k</italic>) (a monotonic increasing function of <italic>k</italic>), would be if there were a strong negative correlation between the number of driver mutations and the number of stem cell divisions by cancer type. This would not be expected–if anything one would expect that the correlation should go in the opposite direction. The organism cannot afford to have tissues where there is a high rate of stem cell divisions, but where a single mutation can lead to cancer. This is supported by the data–indeed the tumors with short latency (leukemia, bone (osteosarcoma), thyroid), and presumably therefore having a smaller number of cancer driver mutations than the remaining (and rather larger) group of epithelial tumors, tend to have numbers of stem-cell mutations per year, or in total, that are less than the mean, and for bone and thyroid cancer are among the smallest values in aggregate (Tables <xref ref-type="table" rid="pone.0150335.t001">1</xref> and <xref ref-type="table" rid="pone.0150335.t002">2</xref>). We have also performed sensitivity analyses excluding the tumors with short latency (leukemia, bone (osteosarcoma), thyroid); the results of this analysis are essentially the same as the main analysis (Tables <xref ref-type="table" rid="pone.0150335.t003">3</xref> and <xref ref-type="table" rid="pone.0150335.t006">6</xref> and Tables A and B in <xref ref-type="supplementary-material" rid="pone.0150335.s001">S1 Text</xref>), suggesting that material bias would not result from such heterogeneity.</p>
<p>It is an inevitable weakness of the analysis that we conduct that we combine across cancer types. We have just single measurements of cell turnover per cancer endpoint, and likewise single estimates of the various cancer risk measures per endpoint. Nevertheless, to the extent that the model of Armitage and Doll, with the generalization we employ to take account of intermediate compartment growth rates [<xref ref-type="bibr" rid="pone.0150335.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0150335.ref012">12</xref>], discussed in the Introduction, provides a unifying framework, with a constant number of driver mutation stages <italic>k</italic>, as discussed above, this may be legitimate.</p>
<p>In recent years there has been movement away from use of the Armitage and Doll model [<xref ref-type="bibr" rid="pone.0150335.ref004">4</xref>], which postulates a series of independent rate-limiting mutations and in the form commonly used also makes use of an approximation to the conditional likelihood, to stochastically “exact” models that allow for intermediate cell proliferation or apoptosis. Examples of this alternative approach include the two-mutation model of Moolgavkar, Venzon, and Knudson [<xref ref-type="bibr" rid="pone.0150335.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0150335.ref026">26</xref>], and various generalizations of this that allow for a larger number of mutational stages [<xref ref-type="bibr" rid="pone.0150335.ref027">27</xref>], and the incorporation of various types of genomic instability [<xref ref-type="bibr" rid="pone.0150335.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0150335.ref029">29</xref>]. US population colon cancer incidence can be described by such a model incorporating just two rate-limiting mutations, combined with a destabilizing mutational event [<xref ref-type="bibr" rid="pone.0150335.ref029">29</xref>–<xref ref-type="bibr" rid="pone.0150335.ref031">31</xref>]. Nevertheless the Armitage-Doll model, or slight modifications thereof, is still much used. For example, Tomasetti <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0150335.ref010">10</xref>] used a modified Armitage-Doll model with adjustment for clonal expansion of cells with various numbers of driver mutations fitted to epidemiological data combined with genome-wide sequencing data to infer that three rate-limiting mutations adequately describe lung and colorectal cancer incidence. We employed the same modified Armitage-Doll model here.</p>
<p>A detailed justification of the ERS measure proposed by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] is not provided in their paper. Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] state that “the greater the absolute value of this product is, the smaller is the evidence for the presence of any environmental or inherited factor acting on that tissue.” They give a numerical example to suggest why this product may perform better in this respect than the corresponding ratio, ln<sub>10</sub>[<italic>CR</italic>] / ln<sub>10</sub>[<italic>D</italic>], but this is the only justification provided. Tomasetti and Vogelstein motivate derivation of the ERS, as determining “when there is high cancer risk of that tissue type relative to its number of stem cell divisions” [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>]. As noted by Potter and Prentice the ERS is calculated “not as the ratio, but as the product, of cancer incidence rates and stem cell division number”, meaning that “the resulting classification into D [deterministic] and R [replicative] tumors does not seem interpretable” [<xref ref-type="bibr" rid="pone.0150335.ref032">32</xref>].</p>
<p>In practice, the score produces odd results. For example melanoma, acute myeloid leukemia and esophageal cancer all have negative scores, putatively suggestive of predominantly stochastic effects, but there are known strong environmental influences on all three [<xref ref-type="bibr" rid="pone.0150335.ref033">33</xref>]. As we have shown, there is little evidence to suggest that this measure, or various other plausible measures based on cell-turnover data assembled by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] are quantitatively associated with the susceptibility of a tissue to radiation- or smoking-associated cancer. Moreover, the slope of the relationship between log[cancer incidence rate] and log[expected number of stem-cell divisions] is much less than 1 (<xref ref-type="table" rid="pone.0150335.t006">Table 6</xref>), and therefore much less than the value of 2–3, or even more, that would be expected from either the Armitage and Doll model [<xref ref-type="bibr" rid="pone.0150335.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0150335.ref004">4</xref>] or other carcinogenesis models [<xref ref-type="bibr" rid="pone.0150335.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0150335.ref028">28</xref>–<xref ref-type="bibr" rid="pone.0150335.ref030">30</xref>], as discussed above in relation to the analysis of <xref ref-type="table" rid="pone.0150335.t003">Table 3</xref>.</p>
<p>A problem with our analysis is that we only have quantitative information on radiation-associated and tobacco-associated cancer risk for a subset of the 31 natural cancer sites considered by Tomasetti and Vogelstein, where radiation or smoking risk data are available. While the significance of the increasing trends of log<sub>10</sub>[lifetime natural cancer incidence risk] <italic>vs</italic> unit of log<sub>10</sub>[cumulative stem-cell divisions] (i.e., <italic>α</italic><sub>1</sub>) is preserved in the sets of radiation- and tobacco-cancer data that we consider, the trends are of somewhat reduced magnitude compared with those in the natural cancer dataset of Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] (<xref ref-type="table" rid="pone.0150335.t006">Table 6</xref>). Their paper [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] has been criticized by O’Callaghan for the somewhat heterogeneous biological data, of rather variable quality [<xref ref-type="bibr" rid="pone.0150335.ref034">34</xref>]. The biological data also came from a number of different populations, and so it may be problematic comparing it with natural cancer incidence risks for a US population. This is therefore also a problem in our analysis, largely based as it is on the Tomasetti and Vogelstein stem-cell turnover data, which we compare with Japanese population radiation risks, or British tobacco risks. Because the radiation- or tobacco-associated risks are not available for the specific cancer subtypes cited by Tomasetti and Vogelstein [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>], we use aggregate (e.g., whole lung, esophagus, brain) radiation- or tobacco-associated risks, and comparable US lifetime cancer incidence risks [<xref ref-type="bibr" rid="pone.0150335.ref013">13</xref>]. Tobacco smoke is for most smokers a largely continuous exposure, in contrast to the instantaneous dose of radiation received by the Japanese atomic bomb survivors; this may have some bearing on the slightly stronger trends we observe for radiation risk. It is possible that some of the variation in smoking-associated risk is related to the degree to which tissues are exposed to the range of carcinogens in tobacco smoke. Thus high risks are found for lung, larynx, esophagus, oropharyngeal, bladder, stomach, kidney, and cervical cancer, less so for most other organs [<xref ref-type="bibr" rid="pone.0150335.ref035">35</xref>]. It is possible that some part of the differences in tissue exposure may overwhelm differences driven by number of cell divisions.</p>
<p>Based on the results of their analysis, Tomasetti and Vogelstein “suggest that only a third of the variation in cancer risk among tissues is attributable to environmental factors or inherited predispositions. The majority is due to “bad luck,” that is, random mutations arising during DNA replication in normal, noncancerous stem cells.” [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] However, it is known that stem-cell division may be caused by external influences, as for example during tissue recovery from cytotoxic agents [<xref ref-type="bibr" rid="pone.0150335.ref036">36</xref>]. Even if it <underline>were</underline> true that random errors during stem-cell division are involved in the etiology of a great majority of cancers, it would be incorrect to infer that most cancers are just due to “bad luck” and do not involve environmental or lifestyle factors. This is a simple consequence of the multistage nature of carcinogenesis, which implies that multiple mutational events contribute to a given cancer. For example, strong skepticism was expressed when, based on extrapolations from epidemiological studies of underground miners, it was projected that about 10–20% of all lung cancers in the U.S. population might be due to radon [<xref ref-type="bibr" rid="pone.0150335.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0150335.ref038">38</xref>]. This seemed unrealistic, given the evidence that smoking accounted for 90% of all lung cancers [<xref ref-type="bibr" rid="pone.0150335.ref035">35</xref>]. However, when it is recognized that the great majority of radon-induced lung cancers also involved smoking, the problem disappears. Indeed even if, say, half of all mutations were due to random errors during stem cell division, the requirement for 3–7 mutations to produce a cancer would imply that the great majority (&gt;85%) of all cancers could involve one or more non-random mutational event. Related arguments have been made by Song and Giovannucci [<xref ref-type="bibr" rid="pone.0150335.ref039">39</xref>]. Epidemiological analysis suggests that in excess of 40% of cancers in the US are caused by exogenous exposures, the dominant cause being tobacco [<xref ref-type="bibr" rid="pone.0150335.ref040">40</xref>]. Regardless of any multiple somatic mutation scenario, it is probably unwise to judge the importance of factors by thinking of them as “residues” after other factors are somehow subtracted out. To judge whether a factor is important, the most reasonable approach to inference on the importance of a factor in relation to some cancer endpoint is to use data where that factor is present.</p>
<p>In summary, the data used by Tomasetti and Vogelstein as the basis of their assertion that “the incorporation of a replicative component as a … quantitative determinant of cancer risk forces rethinking of our notions of cancer causation” [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] is in conflict with predictions of a theoretical multistage model of carcinogenesis. Their statement that “if the ERS for a tissue type is high … then one would expect that environmental … factors would play a relatively more important role in that cancer’s risk” [<xref ref-type="bibr" rid="pone.0150335.ref002">2</xref>] is in conflict with the lack of correlation between ERS and other stem-cell proliferation indices and radiation- or smoking-related cancer risk.</p>
</sec>
<sec id="sec010">
<title>Supporting Information</title>
<supplementary-material id="pone.0150335.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.s001" xlink:type="simple">
<label>S1 Text</label>
<caption>
<title>Supplementary Analysis.</title>
<p>Tables A, B, Analogs of Tables <xref ref-type="table" rid="pone.0150335.t004">4</xref> and <xref ref-type="table" rid="pone.0150335.t005">5</xref>, omitting tumors with short latency (leukemia, thyroid, bone).</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0150335.s002" mimetype="application/zip" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.s002" xlink:type="simple">
<label>S2 Text</label>
<caption>
<title>Datasets used for analysis.</title>
<p>(ZIP)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0150335.s003" mimetype="application/zip" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.s003" xlink:type="simple">
<label>S3 Text</label>
<caption>
<title>R code and output files used for analysis.</title>
<p>(ZIP)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0150335.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0150335.s004" xlink:type="simple">
<label>S4 Text</label>
<caption>
<title>Supplementary Figures A, B.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors are grateful for the detailed and helpful comments of Dr Julian Preston, Dr Christophe Badie and the three referees.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0150335.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>International Commission on Radiological Protection</collab>. <article-title>Stem cell biology with respect to carcinogenesis aspects of radiological protection. ICRP Publication 131</article-title>. <source>Ann ICRP</source>. <year>2015</year>;<volume>44</volume>(<issue>3–4</issue>):<fpage>1</fpage>–<lpage>357</lpage>.</mixed-citation></ref>
<ref id="pone.0150335.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tomasetti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vogelstein</surname> <given-names>B</given-names></name>. <article-title>Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions</article-title>. <source>Science</source>. <year>2015</year>;<volume>347</volume>(<issue>6217</issue>):<fpage>78</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1260825" xlink:type="simple">10.1126/science.1260825</ext-link></comment> <object-id pub-id-type="pmid">25554788</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doll</surname> <given-names>R</given-names></name>. <article-title>Age distribution of cancer: implications for models of carcinogenesis</article-title>. <source>J Roy Statist Soc Series A—General</source>. <year>1971</year>;<volume>134</volume>:<fpage>133</fpage>–<lpage>66</lpage>.</mixed-citation></ref>
<ref id="pone.0150335.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Armitage</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Doll</surname> <given-names>R</given-names></name>. <article-title>The age distribution of cancer and a multi-stage theory of carcinogenesis</article-title>. <source>Br J Cancer</source>. <year>1954</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>. <object-id pub-id-type="pmid">13172380</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref005"><label>5</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Peto</surname> <given-names>R</given-names></name>. <chapter-title>Epidemiology, multistage models, and short-term mutagenicity tests</chapter-title>. In: <name name-style="western"><surname>Hiatt</surname> <given-names>HH</given-names></name>, <name name-style="western"><surname>Winsten</surname> <given-names>JA</given-names></name>, editors. <source>Origins of human cancer</source>. <publisher-loc>Cold Spring Harbor</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory</publisher-name>; <year>1977</year>. p. <fpage>1403</fpage>–<lpage>28</lpage>.</mixed-citation></ref>
<ref id="pone.0150335.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Day</surname> <given-names>NE</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>CC</given-names></name>. <article-title>Multistage models and primary prevention of cancer</article-title>. <source>J Natl Cancer Inst</source>. <year>1980</year>;<volume>64</volume>(<issue>4</issue>):<fpage>977</fpage>–<lpage>89</lpage>. <object-id pub-id-type="pmid">6929006</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brown</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>KC</given-names></name>. <article-title>A new method for the analysis of cohort studies: implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure</article-title>. <source>Environ Health Perspect</source>. <year>1983</year>;<volume>50</volume>:<fpage>293</fpage>–<lpage>308</lpage>. <object-id pub-id-type="pmid">6873020</object-id>; PubMed Central PMCID: PMCPMC1569231.</mixed-citation></ref>
<ref id="pone.0150335.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname> <given-names>DC</given-names></name>. <article-title>A model for dose rate and duration of exposure effects in radiation carcinogenesis</article-title>. <source>EnvironHealth Perspect</source>. <year>1990</year>;<volume>87</volume>:<fpage>163</fpage>–<lpage>71</lpage>.</mixed-citation></ref>
<ref id="pone.0150335.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mazumdar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Redmond</surname> <given-names>CK</given-names></name>, <name name-style="western"><surname>Enterline</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Marsh</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Costantino</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>SY</given-names></name>, <etal>et al</etal>. <article-title>Multistage modeling of lung cancer mortality among arsenic-exposed copper-smelter workers</article-title>. <source>Risk Anal</source>. <year>1989</year>;<volume>9</volume>(<issue>4</issue>):<fpage>551</fpage>–<lpage>63</lpage>. <object-id pub-id-type="pmid">2608948</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tomasetti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Marchionni</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Nowak</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Parmigiani</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Vogelstein</surname> <given-names>B</given-names></name>. <article-title>Only three driver gene mutations are required for the development of lung and colorectal cancers</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2015</year>;<volume>112</volume>(<issue>1</issue>):<fpage>118</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1421839112" xlink:type="simple">10.1073/pnas.1421839112</ext-link></comment> <object-id pub-id-type="pmid">25535351</object-id>; PubMed Central PMCID: PMC4291633.</mixed-citation></ref>
<ref id="pone.0150335.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Little</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Hawkins</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Charles</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Hildreth</surname> <given-names>NG</given-names></name>. <article-title>Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks</article-title>. <source>Radiat Res</source>. <year>1992</year>;<volume>132</volume>(<issue>2</issue>):<fpage>207</fpage>–<lpage>21</lpage>. <object-id pub-id-type="pmid">1438703</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Durrett</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Moseley</surname> <given-names>S</given-names></name>. <article-title>Evolution of resistance and progression to disease during clonal expansion of cancer</article-title>. <source>Theor Popul Biol</source>. <year>2010</year>;<volume>77</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tpb.2009.10.008" xlink:type="simple">10.1016/j.tpb.2009.10.008</ext-link></comment> <object-id pub-id-type="pmid">19896491</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref013"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Surveillance Epidemiology and End Results (SEER) Program. SEER Stat Fact Sheets.: National Cancer Institute; [updated 8-7-2015]. US lifetime risk of cancer incidence, based on 2010–2 data.]. Available: <ext-link ext-link-type="uri" xlink:href="http://seer.cancer.gov/" xlink:type="simple">http://seer.cancer.gov/</ext-link>. Accessed August 7 2015.</mixed-citation></ref>
<ref id="pone.0150335.ref014"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). UNSCEAR 2006 Report. Annex A. Epidemiological Studies of Radiation and Cancer. New York: United Nations; 2008. p. 13–322.</mixed-citation></ref>
<ref id="pone.0150335.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doll</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Peto</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Boreham</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sutherland</surname> <given-names>I</given-names></name>. <article-title>Mortality from cancer in relation to smoking: 50 years observations on British doctors</article-title>. <source>Br J Cancer</source>. <year>2005</year>;<volume>92</volume>(<issue>3</issue>):<fpage>426</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.bjc.6602359" xlink:type="simple">10.1038/sj.bjc.6602359</ext-link></comment> <object-id pub-id-type="pmid">15668706</object-id>; PubMed Central PMCID: PMC2362086.</mixed-citation></ref>
<ref id="pone.0150335.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Preston</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Ron</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Tokuoka</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Funamoto</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nishi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Soda</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Solid cancer incidence in atomic bomb survivors: 1958–1998</article-title>. <source>RadiatRes</source>. <year>2007</year>;<volume>168</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>64</lpage>. [pii]; <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1667/RR0763.1" xlink:type="simple">10.1667/RR0763.1</ext-link></comment></mixed-citation></ref>
<ref id="pone.0150335.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ozasa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Shimizu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Suyama</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kasagi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Soda</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Grant</surname> <given-names>EJ</given-names></name>, <etal>et al</etal>. <article-title>Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: an overview of cancer and noncancer diseases</article-title>. <source>Radiat Res</source>. <year>2012</year>;<volume>177</volume>(<issue>3</issue>):<fpage>229</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1667/RR2629.1" xlink:type="simple">10.1667/RR2629.1</ext-link></comment> [pii]. <object-id pub-id-type="pmid">22171960</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>International Commission on Radiological Protection</collab>. <article-title>The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103</article-title>. <source>Ann ICRP</source>. <year>2007</year>;<volume>37</volume>(<issue>2–4</issue>):<fpage>1</fpage>–<lpage>332</lpage>. doi: S0146-6453(07)00031-0 [pii]; <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.icrp.2007.10.003" xlink:type="simple">10.1016/j.icrp.2007.10.003</ext-link></comment> <object-id pub-id-type="pmid">18082557</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref019"><label>19</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation NRC</collab>. <source>Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII—Phase 2</source>. <publisher-loc>Washington, DC, USA</publisher-loc>: <publisher-name>National Academy Press</publisher-name>; <year>2006</year>. <fpage>1</fpage>–<lpage>406</lpage> p.</mixed-citation></ref>
<ref id="pone.0150335.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Little</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Wakeford</surname> <given-names>R</given-names></name>. <article-title>How is the risk of radiation-induced cancer influenced by background risk factors? Invited commentary on "A method for determining weights for excess relative risk and excess absolute risk when applied in the calculation of lifetime risk of cancer from radiation exposure" by Walsh and Schneider (2012)</article-title>. <source>RadiatEnvironBiophys</source>. <year>2013</year>;<volume>52</volume>(<issue>1</issue>):<fpage>147</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00411-012-0442-9" xlink:type="simple">10.1007/s00411-012-0442-9</ext-link></comment></mixed-citation></ref>
<ref id="pone.0150335.ref021"><label>21</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Rao</surname> <given-names>CR</given-names></name>. <chapter-title>Linear statistical inference and its applications</chapter-title>. <edition>2nd edition</edition>. <publisher-loc>Singapore</publisher-loc>: <publisher-name>John Wiley &amp; Sons, Inc</publisher-name>; <year>2002</year>. <fpage>1</fpage>–<lpage>625</lpage> p.</mixed-citation></ref>
<ref id="pone.0150335.ref022"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">R Project version 3.2.2. R version 3.2.2. Available: <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/" xlink:type="simple">http://www.r-project.org/</ext-link>. 2015.</mixed-citation></ref>
<ref id="pone.0150335.ref023"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Tomasetti C, Vogelstein B. Musings on the theory that variation in cancer risk among tissues can be explained by the number of divisions of normal stem cells. arXiv. 2015;arXiv:1501.05035v3 [stat.AP]:1–17. Epub 12/16/2015.</mixed-citation></ref>
<ref id="pone.0150335.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Powers</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Hannun</surname> <given-names>YA</given-names></name>. <article-title>Substantial contribution of extrinsic risk factors to cancer development</article-title>. <source>Nature</source>. <year>2016</year>;<volume>529</volume>(<issue>7584</issue>):<fpage>43</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature16166" xlink:type="simple">10.1038/nature16166</ext-link></comment> <object-id pub-id-type="pmid">26675728</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moolgavkar</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Venzon</surname> <given-names>DJ</given-names></name>. <article-title>Two-event models for carcinogenesis: incidence curves for childhood and adult tumors</article-title>. <source>Math Biosci</source>. <year>1979</year>;<volume>47</volume>(<issue>1–2</issue>):<fpage>55</fpage>–<lpage>77</lpage>.</mixed-citation></ref>
<ref id="pone.0150335.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knudson</surname> <given-names>AG</given-names> <suffix>Jr</suffix></name>. <article-title>Mutation and cancer: statistical study of retinoblastoma</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1971</year>;<volume>68</volume>(<issue>4</issue>):<fpage>820</fpage>–<lpage>3</lpage>. <object-id pub-id-type="pmid">5279523</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Little</surname> <given-names>MP</given-names></name>. <article-title>Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll</article-title>. <source>Biometrics</source>. <year>1995</year>;<volume>51</volume>(<issue>4</issue>):<fpage>1278</fpage>–<lpage>91</lpage>. <object-id pub-id-type="pmid">8589222</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Little</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Wright</surname> <given-names>EG</given-names></name>. <article-title>A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data</article-title>. <source>Math Biosci</source>. <year>2003</year>;<volume>183</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>34</lpage>. doi: S0025556403000403 [pii]. <object-id pub-id-type="pmid">12711407</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Little</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Vineis</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>G</given-names></name>. <article-title>A stochastic carcinogenesis model incorporating multiple types of genomic instability fitted to colon cancer data</article-title>. <source>J Theor Biol</source>. <year>2008</year>;<volume>254</volume>(<issue>2</issue>):<fpage>229</fpage>–<lpage>38</lpage>. doi: S0022-5193(08)00274-9 [pii]; <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jtbi.2008.05.027" xlink:type="simple">10.1016/j.jtbi.2008.05.027</ext-link></comment> <object-id pub-id-type="pmid">18640693</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Little</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>G</given-names></name>. <article-title>Stochastic modelling of colon cancer: is there a role for genomic instability?</article-title> <source>Carcinogenesis</source>. <year>2007</year>;<volume>28</volume>(<issue>2</issue>):<fpage>479</fpage>–<lpage>87</lpage>. [pii]; <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/carcin/bgl173" xlink:type="simple">10.1093/carcin/bgl173</ext-link></comment> <object-id pub-id-type="pmid">16973671</object-id></mixed-citation></ref>
<ref id="pone.0150335.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nowak</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Komarova</surname> <given-names>NL</given-names></name>, <name name-style="western"><surname>Sengupta</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jallepalli</surname> <given-names>PV</given-names></name>, <name name-style="western"><surname>Shih</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Vogelstein</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>The role of chromosomal instability in tumor initiation</article-title>. <source>ProcNatlAcadSciUSA</source>. <year>2002</year>;<volume>99</volume>(<issue>25</issue>):<fpage>16226</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.202617399" xlink:type="simple">10.1073/pnas.202617399</ext-link></comment> [pii].</mixed-citation></ref>
<ref id="pone.0150335.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Potter</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Prentice</surname> <given-names>RL</given-names></name>. <article-title>Cancer risk: tumors excluded</article-title>. <source>Science</source>. <year>2015</year>;<volume>347</volume>(<issue>6223</issue>):<fpage>727</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aaa6507" xlink:type="simple">10.1126/science.aaa6507</ext-link></comment> <object-id pub-id-type="pmid">25656658</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref033"><label>33</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Armstrong</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Brenner</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Baverstock</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Cardis</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Green</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Guilmette</surname> <given-names>RA</given-names></name>, <etal>et al</etal>. <chapter-title>Radiation. Volume 100D. A review of human carcinogens</chapter-title>. <publisher-loc>Lyon, France</publisher-loc>: <publisher-name>International Agency for Research on Cancer</publisher-name>; <year>2012</year>. <fpage>1</fpage>–<lpage>341</lpage> p.</mixed-citation></ref>
<ref id="pone.0150335.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Callaghan</surname> <given-names>M</given-names></name>. <article-title>Cancer risk: accuracy of literature</article-title>. <source>Science</source>. <year>2015</year>;<volume>347</volume>(<issue>6223</issue>):<fpage>729</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aaa6212" xlink:type="simple">10.1126/science.aaa6212</ext-link></comment> <object-id pub-id-type="pmid">25678652</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref035"><label>35</label><mixed-citation publication-type="book" xlink:type="simple"><collab>US. Surgeon General</collab>. <source>The health consequences of smoking: a report of the Surgeon General</source>. <publisher-loc>Washington, D.C.</publisher-loc>: <publisher-name>Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health</publisher-name>; <year>2004</year>. 941 p.</mixed-citation></ref>
<ref id="pone.0150335.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Otsuka</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hamada</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Magae</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hoshi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Iwasaki</surname> <given-names>T</given-names></name>. <article-title>Ionizing radiation leads to the replacement and <italic>de novo</italic> production of colonic Lgr5<sup>+</sup> stem cells</article-title>. <source>Radiat Res</source>. <year>2013</year>;<volume>179</volume>(<issue>6</issue>):<fpage>637</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1667/RR3253.1" xlink:type="simple">10.1667/RR3253.1</ext-link></comment> <object-id pub-id-type="pmid">23627781</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref037"><label>37</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Committee on Health Risks of Exposure to Radon (BEIR VI)</collab>. <collab>US National Academy of Sciences</collab>. <collab>National Research Council</collab>. <collab>Committee on Health Risks of Exposure to Radon (BEIR VI)</collab>. <chapter-title>Health effects of exposure to radon</chapter-title>. <publisher-loc>Washington, DC, USA</publisher-loc>: <publisher-name>National Academy Press</publisher-name>; <year>1999</year>.</mixed-citation></ref>
<ref id="pone.0150335.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Puskin</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>Y</given-names></name>. <article-title>A retrospective look at Rn-induced lung cancer mortality from the viewpoint of a relative risk model</article-title>. <source>Health Phys</source>. <year>1988</year>;<volume>54</volume>(<issue>6</issue>):<fpage>635</fpage>–<lpage>43</lpage>. <object-id pub-id-type="pmid">3378895</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Song</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Giovannucci</surname> <given-names>EL</given-names></name>. <article-title>Cancer risk: many factors contribute</article-title>. <source>Science</source>. <year>2015</year>;<volume>347</volume>(<issue>6223</issue>):<fpage>728</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aaa6094" xlink:type="simple">10.1126/science.aaa6094</ext-link></comment> <object-id pub-id-type="pmid">25678651</object-id>.</mixed-citation></ref>
<ref id="pone.0150335.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doll</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Peto</surname> <given-names>R</given-names></name>. <article-title>The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today</article-title>. <source>J Natl Cancer Inst</source>. <year>1981</year>;<volume>66</volume>(<issue>6</issue>):<fpage>1191</fpage>–<lpage>308</lpage>. <object-id pub-id-type="pmid">7017215</object-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>